PHARMACY

CVS Health issues a statement praising PBMs for saving Ohio taxpayers money, while noting that the company will continue to help Ohio Medicaid clients manage their drug costs.

Alembic gets tentative approval from the FDA for a generic version of Allergan's Latisse ophthalmic solution. The product has a market value of approximately $63 million.

Knowledge of last year's high flu levels is encouraging consumers to get vaccinated this season, according to a recent survey by CVS Health.

The product had a market value of approximately $324 million for the 12-month period ending April 2018, according to IQVIA data.

Mylan's tadalafil tablets are the first generic version of Eli Lilly's Adcirca for pulmonary arterial hypertension.

Alongside it shedding its pharmaceutical business, Perrigo said it had entered an exclusive agreement with a subsidiary of Kenilworth, N.J.-based Merck to develop an over-the-counter formulation of Merck’s Nasonex nasal spray

NACDS commended the passage of Massachusetts House Bill 4742 that requires that prescriptions for Schedule II through VI controlled substances in the Commonwealth of Massachusetts must be issued as an electronic prescription from the person issuing the prescription to a pharmacy.

Cipla is launching the generic version of Genentech's Xeloda in two dosage strengths in partnership with MSN Laboratories